CIBC World Markets’s AtriCure ATRC Stock Holding History

CIBC World Markets’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,504	Closed	-$339K	–	1586
2025 Q1	$339K	Buy	+10,504	New	+$390K	﹤0.01%	1201

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

CIBC World Markets's ATRC Position: Q2 2025 in Review

CIBC World Markets sold out of AtriCure (ATRC) in Q2 2025, closing a stake of 10,504 shares — an estimated $339K sold.

CIBC World Markets first reported a position in ATRC in Q1 2025 and held it in 1 quarter. The position peaked at $339K in Q1 2025. 201 funds tracked by Wall St. Rank hold ATRC as of Q2 2025.

CIBC World Markets reported no remaining AtriCure position as of Q2 2025 after selling out during the quarter.
CIBC World Markets sold 10,504 AtriCure shares in Q2 2025, an estimated $339K.
CIBC World Markets first reported a position in AtriCure in Q1 2025 and held it in 1 quarter.
CIBC World Markets's AtriCure position peaked at $339K in Q1 2025.
201 funds tracked by Wall St. Rank held AtriCure as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.